1. Home
  2. NCRA vs SYBX Comparison

NCRA vs SYBX Comparison

Compare NCRA & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • SYBX
  • Stock Information
  • Founded
  • NCRA 2002
  • SYBX N/A
  • Country
  • NCRA Taiwan
  • SYBX United States
  • Employees
  • NCRA N/A
  • SYBX N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCRA Consumer Staples
  • SYBX Health Care
  • Exchange
  • NCRA Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • NCRA 13.9M
  • SYBX 13.6M
  • IPO Year
  • NCRA N/A
  • SYBX N/A
  • Fundamental
  • Price
  • NCRA $1.00
  • SYBX $1.11
  • Analyst Decision
  • NCRA
  • SYBX
  • Analyst Count
  • NCRA 0
  • SYBX 0
  • Target Price
  • NCRA N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • NCRA 83.1K
  • SYBX 11.1K
  • Earning Date
  • NCRA 05-06-2025
  • SYBX 05-20-2025
  • Dividend Yield
  • NCRA N/A
  • SYBX N/A
  • EPS Growth
  • NCRA N/A
  • SYBX N/A
  • EPS
  • NCRA N/A
  • SYBX 0.21
  • Revenue
  • NCRA $17,013,132.00
  • SYBX N/A
  • Revenue This Year
  • NCRA N/A
  • SYBX N/A
  • Revenue Next Year
  • NCRA N/A
  • SYBX N/A
  • P/E Ratio
  • NCRA N/A
  • SYBX $5.25
  • Revenue Growth
  • NCRA N/A
  • SYBX N/A
  • 52 Week Low
  • NCRA $0.70
  • SYBX $0.90
  • 52 Week High
  • NCRA $2.09
  • SYBX $1.91
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 53.09
  • SYBX 45.73
  • Support Level
  • NCRA $0.87
  • SYBX $1.00
  • Resistance Level
  • NCRA $1.03
  • SYBX $1.19
  • Average True Range (ATR)
  • NCRA 0.12
  • SYBX 0.09
  • MACD
  • NCRA 0.00
  • SYBX 0.00
  • Stochastic Oscillator
  • NCRA 52.38
  • SYBX 55.00

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: